JAVITT JONATHAN C (Chief Executive Officer) sold 3.0% of their position (400K shares) of NRX PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $400.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/9/2022ACC: 0001415889-22-012324
DirectorOfficer10% Owner· Chief Executive Officer
Since May 2021
-400K
Net shares
Net seller
$400.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
400K disposed
Non-Derivative Transactions1
Common Stock, par value $0.001 per share
Indirect
Shares
−400K
Price / share
$1.00
Trade value
$400K
% of position
3.0%
12/7/2022
13.30M→12.90M
Total
Net shares
−400K
Net value
-$400K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 12/7/2022 | S · Sale | −400K | $1.00 | $400K | 3.0% | 13.30M | 12.90M |
| Total | −400K | -$400K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock, par value $0.001 per share
DirectShares owned146.33K
Common Stock, par value $0.001 per share
IndirectShares owned1.42M
Total
146.33K direct·1.42M indirect1.57M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 per share | 146.33K | Direct |
| Common Stock, par value $0.001 per share | 1.42M | Indirect |
| Total | 1.57M | 146.33K direct·1.42M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported